BUSINESS

More news
Valeant

Valeant Trumps Endo With $10.96 Billion Bid For Salix Pharma

Valeant Pharmaceuticals International Inc. increased its takeover offer for Salix Pharmaceuticals Inc. to $10.96 billion in cash on Monday, eliminating Endo International Plc, the only other bidder for the maker of gastrointestinal drugs.

Pages

IBT Spotlight

We Help Businesses Find B2B Service Providers They Can Trust.